Back to Directory
pharmaceuticals logo

Jubilant Pharmova Limited | Company Profile

12/1/2025

Contact Information

👤
Jubilant Pharmova Limited
🏢
Jubilant Pharmova Limited
📍
Plot No. 1, Sector-16A, Noida, Uttar Pradesh 201301, IN

Industry & Market

Primary Industry
pharmaceuticals
All Industries
pharmaceuticalschemicals
Location
Noida, Uttar Pradesh, India
Public Trading
BSE: JUBLPHARMA.BO

Company Metrics

👥Total Employees
604
⚙️Engineering
177
💼Sales Team
134
📈Marketing
27
📅Founded
2021
💰Revenue
846.9M

Funding Information

Annual Revenue
$846,868,000
Publicly traded company

Headcount Distribution

Total Employees
604
Departments
19

By Department

Department Breakdown

Engineering
Sales
Human Resources
Information Technology
Business Development
Marketing
Others

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Development

Bootstrap Framework

Video & Media

Vimeo

Email & Communication

Outlook
Total: 15 technologies

Keywords & Focus Areas

pharmaceuticalspharmachemicalsspeciality chemicalspharmaceutical manufacturingpharmaceutical and medicine manufacturinghealthcare equipment & suppliesallergy vaccinesenvironmental policiescontract manufacturingsustainable pharma practicesadvanced manufacturing technologycontract research organizationsmedical devicesglobal pharma supplyinnovationallergen extract manufacturingbiopharmaceutical researchcontract manufacturing organizationradiopharma distribution network+10 more
30 total keywords

Jubilant Pharmova Limited

Overview

Jubilant Pharmova Limited is a global integrated pharmaceutical company based in Uttar Pradesh, India. Founded in 1978, it operates across multiple business segments, including Specialty Pharmaceuticals, Contract Development and Manufacturing Organization (CDMO), Generics, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The company reported revenues of approximately $810 million in 2023 and has a strong presence in North America and India.

The Specialty Pharmaceuticals segment includes Radiopharmaceuticals and Allergy Immunotherapy products, while the CDMO segment offers sterile injectable manufacturing and active pharmaceutical ingredients. Jubilant Pharmova also produces finished dosage formulations in its Generics segment and provides contract research services through Jubilant Biosys Limited. With a diverse portfolio focused on oncology and autoimmune disorders, it serves customers in over 85 countries, primarily in the pharmaceutical, biotechnology, and nuclear medicine industries.

Basic Information

Industry pharmaceuticals
Revenue $846.9M
Headquarters Plot No. 1, Sector-16A, Noida, Uttar Pradesh 201301, India

Contact Details

Key Focus Areas & Initiatives

  • Pharmaceuticals
  • Pharma
  • Chemicals
  • Speciality chemicals
  • Pharmaceutical manufacturing
  • Pharmaceutical and medicine manufacturing
  • Healthcare equipment & supplies
  • Allergy vaccines
  • Environmental policies
  • Contract manufacturing
  • Sustainable pharma practices
  • Advanced manufacturing technology
  • Contract research organizations
  • Medical devices
  • Global pharma supply
  • Innovation
  • Allergen extract manufacturing
  • Biopharmaceutical research
  • Contract manufacturing organization
  • Radiopharma distribution network
  • Research and development in biotechnology
  • Drug discovery
  • Clinical research services
  • Manufacturing facilities
  • Oncology
  • Supply chain
  • Parenteral formulations
  • Regulatory compliance
  • B2B
  • Drug discovery services
  • Biotech development
  • Active pharmaceutical ingredients
  • Global presence
  • Parenteral products
  • Generics
  • Supply chain management
  • Radiopharma
  • Research and development
  • Sterile injectables
  • Radiopharmaceuticals
  • Biotechnology
  • Life sciences
  • Sustainable pharma
  • Energy conservation
  • Clinical-stage medicines
  • Biomedical waste management
  • Radiopharmaceutical development
  • Biopharma innovation
  • Clinical-stage biopharma
  • Allergy immunotherapy
  • Precision oral medicines
  • Parenteral drug manufacturing
  • Sustainable development
  • Therapeutic development
  • Biotech research centers
  • Contract research
  • Innovative medicines
  • Sustainability
  • API manufacturing
  • Regulatory approvals
  • Customer retention
  • Corporate social responsibility
  • Biopharmaceuticals
  • Novel drugs
  • Services
  • Clinical biopharmaceuticals
  • CDMO
  • Contract research organization
  • Precision medicines
  • Oncology therapies
  • Autoimmune disorders
  • Manufacturing
  • Global pharma
  • Clinical trials
  • Intellectual property
  • Business excellence
  • Investor relations
  • Environmental compliance
  • Biodiversity policy
  • Risk management
  • Investor feedback
  • Pharmaceutical innovation
  • Healthcare solutions
  • Injectable products
  • Ophthalmic manufacturing
  • Vaccine production
  • Clinical stage
  • Market regulation
  • Quality assurance
  • Facility operations
  • Stakeholder engagement
  • Financial reporting
  • Corporate governance
  • Shareholder information
  • Global operations
  • Corporate philosophy
  • Research centers
  • Drug development
  • Pharmaceutical supply chain
  • Portfolio management
  • Healthcare investments
  • Compliance training
  • Employee engagement
  • Diversity and inclusion
  • Healthcare
  • Distribution
  • Transportation & logistics
  • Medical
  • Mechanical or industrial engineering
  • Hospital & health care
  • Logistics & supply chain
  • Research & development
  • Environmental services
  • Renewables & environment
  • Health care
  • Health, wellness & fitness

Technologies Used

  • Adobe Media Optimizer
  • Bootstrap Framework
  • Cedexis Radar
  • Google Analytics
  • Google Font API
  • Google Tag Manager
  • Indeed
  • Microsoft Office 365
  • Mobile Friendly
  • Outlook
  • Pardot
  • Remote
  • Salesforce
  • Vimeo
  • reCAPTCHA

Affiliated Organizations & Regional Branches

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free
SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube